Investigation on bile acid receptor regulators. Discovery of cholanoic acid derivatives with dual G-protein coupled bile acid receptor 1 (GPBAR1) antagonistic and farnesoid X receptor (FXR) modulatory activity

Steroids. 2016 Jan:105:59-67. doi: 10.1016/j.steroids.2015.11.003. Epub 2015 Dec 1.

Abstract

Bile acids, the end products of cholesterol metabolism, activate multiple mechanisms through the interaction with membrane G-protein coupled receptors including the bile acid receptor GPBAR1 and nuclear receptors such as the bile acid sensor, farnesoid X receptor (FXR). Even if dual FXR/GPBAR1 agonists are largely considered a novel opportunity in the treatment of several liver and metabolic diseases, selective targeting of one of these receptors represents an attractive therapeutic approach for a wide range of disorders in which dual modulation is associated to severe side effects. In the present study we have investigated around the structure of LCA generating a small library of cholane derivatives, endowed with dual FXR agonism/GPBAR1 antagonism. To the best of our knowledge, this is the first report of bile acid derivatives able to antagonize GPBAR1.

Keywords: Bile acids; FXR modulators; Farnesoid X receptor; G protein-coupled bile acid receptor; GPBAR1 antagonists.

MeSH terms

  • Bile Acids and Salts / chemistry
  • Bile Acids and Salts / pharmacology*
  • Cholic Acids / chemistry
  • Cholic Acids / pharmacology*
  • HEK293 Cells
  • Hep G2 Cells
  • Humans
  • Receptors, Cytoplasmic and Nuclear / genetics
  • Receptors, Cytoplasmic and Nuclear / metabolism*
  • Receptors, G-Protein-Coupled / genetics
  • Receptors, G-Protein-Coupled / metabolism*
  • Transcriptional Activation / drug effects

Substances

  • Bile Acids and Salts
  • Cholic Acids
  • GPBAR1 protein, human
  • Receptors, Cytoplasmic and Nuclear
  • Receptors, G-Protein-Coupled
  • farnesoid X-activated receptor
  • cholanic acid